DOCSLIB.ORG

February 2020 ` 50 News from China China-India Review

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
February 2020 ` 50 News from China China-India Review Vol. XXXII | No.2 | February 2020 ` 50 NEWS FROM CHINA CHINA-INDIA REVIEW PEOPle’s WAR CHINA SHALL OVERCOME PEOPLE POWER MARCHING TOGETHER H.E. SUN WEIDONG From Ambassador’s Desk China’s Ambassador to India China Unites to Win People’s War nation’s strength is tested in difficult of the Political Bureau and decided to set up times. The Chinese leadership and the Central Leading Group on Responding to Apeople have united and joined hands to COVID-19 Outbreak. It has never happened defeat the deadly COVID-19 (novel coronavirus before in Chinese history to have this highest- pneumonia) epidemic. The Chinese government level meeting on the first day of the Spring has taken the most comprehensive, rigorous Festival. It demonstrated that for President Xi and thorough prevention and control measures. curbing the epidemic is foremost priority and We have been working literally 24x7 to win this he is ready to leave no stone unturned in this “People’s War,” as President Xi has said. mission. The results of these cumulative efforts show In this battle against the epidemic, we are a new dawn breaking through darkness. The reassured by growing international support recovery rate of COVID-19 patients in Hubei and solidarity with China. In this context, I will Province surged from 7.14% on Feb. 12 to 53.81% like to thank Prime Minister Narendra Modi on March 2. There is a sharp drop in the fatality for writing a letter to President Xi, expressing rate, with 3,728 patients in severe and critical India’s solidarity with China. Like true conditions cured of the infection. Till today, neighbours and friends, China and India are more than 50,000 patients have recovered and actively collaborating on epidemic prevention been discharged from hospitals. The number and control. We have taken care to keep India of new suspected cases in China continues to informed and updated of the epidemic situation decline to less than 200 a day. in China at various levels. We promptly Clearly, the last few weeks since the outbreak provided necessary assistance and convenience of the deadly epidemic have been trying, but for the return of Indian citizens in Hubei, and at the same time it has brought out the best in ensured the health and safety of Indian nationals the Chinese people. As we continue to wage in China. this epidemic war, I would like to highlight Friends, difficult situations also reveal three keywords: Confidence, Compassion and the true nature and depth of friendship. I am Cooperation. touched by spontaneous expressions of support As President Xi Jinping points out, we have by ordinary Indian people. This epidemic, by full confidence, capability and determination to default, offers new opportunities for deepening prevail over the epidemic at an early date. Our China-India cooperation in the 70th year of confidence comes from the strong leadership establishment of formal diplomatic relations of the Communist Party of China. President Xi between our two countries. I am confident that Jinping gave instructions on the prevention and the 70th anniversary events planned for this control of the epidemic as early as January 7 year will not be affected. Let us join hands to when he convened the meeting of the Standing work together as China’s early victory over the Committee of the Political Bureau of the CPC epidemic will be beneficial to the development Central Committee. On January 25, the very first of both China and India as well as the global day of the Spring Festival, the most important economy. holiday in China, President Xi convened another meeting of the Standing Committee NEWS FROM CHINA | CHINA-INDIA REVIEW |FEBRUARY 2020 | 3 NEWS FROM CHINA CHINA-INDIA REVIEW Vol XXXII | No. 2 | February 2020 Editor-in-Chief : Ji Rong Associate Editors Chang Peilin, Cai Xiaotian CON TENTS Desk Yao Yuanmei CHINA FIGHTS COVID-19 Zu Jian • China is Courageous, will Rise & Overcome: Xi 6 Han Meng • Xi Vows to Win People’s War Against Shweta Aggarwal 10 COVID-19 Published and Printed by Ji Rong, Press Counsellor • Improve Mechanism for Epidemic Control: Xi 12 Embassy of the People’s Republic of China • Li Inspects Epidemic Prevention Work at in India 14 50-D, Shantipath, Chanakyapuri Beijing Station New Delhi- 110021 • China Pushes for Differentiated Measures to 15 Tel: 011-26881249 Battle Coronavirus Fax: 011-26882024 Website: http://in.china-embassy.org • Wang Updates Munich Conference on China’s 16 Battle Against COVID-19 Contact: [email protected] Printed at M/s Advantage Offset B-256, Naraina Industrial Area, Phase-I, Delhi-110028 Consultant TGII Media Private Limited Website of Foreign Ministry of China www.mfa.gov.cn www.fmprc.gov.cn Contact: [email protected] COMBATING & PREVENTING COVID-19 Chinese Ambassador’s Twitter Sun Weidong@China_Amb_India • Chinese Firms Fast-track Vaccine 18 RNI No.: 47440/88 Development Postal Regd. No DL-SW-16/4034/18-20 • China Ensures Medical Supplies for 20 E-book & PDF version Frontline Medics (http://in.china-embassy.org) • Drug Trials for Coronavirus Show 21 Disclaimer Efficacy, says Chinese Official All rights reserved throughout the world. Reproduction in any manner is prohibited. • Robots, the New Chinese Vanguard 24 Against COVID-19 BOARD OF ADVISORS Zhu Xiaohong, Counsellor, Embassy of the People’s Republic of China in India Manish Chand, CEO, TGII Media Private Limited & India Writes Network Mohammed Saqib, Secretary-General, India China Economic and Cultural Council B. R. Deepak, Professor, JNU Kaushal Goyal, CEO, GBD Books CON TENTS PHOTO FEATURES • Destination Hubei : Shoulder-to-Shoulder 26 • In Sickness & In Health: A Couple Joins 30 Hands • Makeshift Hospital: Rising to the Occasion 32 GLOBAL SUPPORT & SOLIDARITY • China Achieves Notable Results in Blocking Covid-19 34 Human-To-Human Transmission: Joint Team • Encouraged by China’s Coronavirus Measures: 35 WHO Chief • World Leaders Support, Laud China’s 36 Anti-Epidemic Efforts CHINA-INDIA CONNECT ECONOMIC MONITOR • Long-term Economic Growth • PM Modi Writes Goodwill Letter 39 56 to Xi, China Thanks India Fundamentals Will Remain Unchanged: President Xi • ‘Unite Together, Fight Together: 40 China Confident of Winning’ • Li calls on Industries to Resume 57 Production for Growth, Stability • Ambassador Sun Answers 48 Questions from the Press • Stimulating Economy: Latest 59 Initiatives • Indian Students: China will Win 50 • Chinese Firms Boost Immunity to the Battle 62 Coronavirus Fallout • Indians Express Solidarity: China 52 • Foreign Firms Resume Business 64 not Alone, We are with You Amid China Epidemic • Chinese Envoy Updates India on 54 • Coronavirus Impact on China, World Steps to Combat Coronavirus Economy to be Limited: Economist 66 NEWS FROM CHINA | CHINA-INDIA REVIEW |FEBRUARY 2020 | 5 54 China is Courageous, will Rise & Overcome: Xi On February 23, Chinese President Xi Jinping stressed unremitting efforts in the prevention and control of the novel coronavirus disease epidemic and coordination in advancing economic and social development. he Chinese nation has experienced many the medical workers, officers and soldiers of the ordeals in its history, but it has never been People’s Liberation Army and comrades from Toverwhelmed. Instead, it has become more various sectors who have been fighting on the and more courageous, growing up and rising front line of epidemic prevention and control. up from the hardships, President Xi said on He expressed his sincere gratitude to February 23. The Chinese leader underlined that compatriots in Hong Kong, Macao and Taiwan, the epidemic situation remains grim and complex and overseas Chinese, as well as to countries, and it is now a most crucial moment to curb the international organizations and friendly people spread, and exhorted the party functionaries and for providing support to the epidemic prevention the local governments to increase coordination and control. to speed up the country’s economic and social development. President Xi also expressed deep condolences to compatriots and medical personnel who lost Xi Jinping, the General Secretary of the their lives in the fight against the epidemic, and Communist Party of China (CPC) Central sincere sympathy to patients and their families Committee, has asked the party committees who are struggling with the disease, as well as and the local governments to continue to make to the families of those who died on duty and the unremitting efforts in the prevention and control deceased patients. work, and resume production in an orderly manner. Efforts should be made to fully unleash The Chinese nation has the huge potential and powerful driving force experienced many ordeals in of China’s development and strive to achieve the goals and tasks for economic and social its history, but it has never development this year, he said. been overwhelmed. Instead, On behalf of the CPC Central Committee, it has become more and more the Chinese leader extended sincere greetings courageous, growing up and rising to party members, officials, and the general public, especially those in the Hubei Province up from the hardships, President and its capital Wuhan, and expressed respect to Xi said on February 23. 6 | NEWS FROM CHINA | CHINA-INDIA REVIEW | FEBRUARY 2020 The February 23 meeting was presided by speed, caused the most extensive infection and is Premier Li Keqiang and attended by CPC Central the most difficult to contain in the country since Committee members, including Li Zhanshu, the founding of the People’s Republic of China, Wang Yang, Wang Huning, Zhao Leji and Han said President Xi. “This is both a crisis and a big Zheng. test for us,” he said, adding that after arduous work, the positive trend in the prevention and Positive Trend Expanding control work is now expanding. “It has been proven that the CPC Central Committee’s President Xi said that since the start of the outbreak judgment on the situation of the epidemic is the CPC Central Committee has attached great accurate, all work arrangements are timely, and importance to the issue, made swift deployment, the measures taken are effective,” President Xi strengthened the centralized, unified leadership said.
Load more

Recommended publications
  • Treatment with Convalescent Plasma for COVID‐19 Patients in Wuhan
    Tangfeng Lv ORCID iD: 0000-0001-7224-8468 Treatment with convalescent plasma for COVID-19 patients in Wuhan, China Mingxiang Ye, MD, PhD Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China Department of Infectious Disease, Unit 4-1, Wuhan Huoshenshan Hospital, Wuhan, China Dian Fu, MD Department of Urology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China Department of Infectious Disease, Unit 4-1, Wuhan Huoshenshan Hospital, Wuhan, China Yi Ren, MD Department of Emergency, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China Department of Infectious Disease, Unit 4-1, Wuhan Huoshenshan Hospital, Wuhan, China This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/jmv.25882. Accepted Article This article is protected by copyright. All rights reserved. Faxiang Wang, MD Department of Emergency, 904 Hospital, Wuxi, China Department of Infectious Disease, Unit 4-1, Wuhan Huoshenshan Hospital, Wuhan, China Dong Wang, MD, PhD Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China Department of Infectious Disease, Unit 4-1, Wuhan Huoshenshan Hospital, Wuhan, China Fang Zhang, MD Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China Department of Infectious Disease, Unit 4-1, Wuhan Huoshenshan Hospital, Wuhan, China Xinyi Xia, MD Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China Department of Laboratory Medicine, Wuhan Huoshenshan Hospital, Wuhan, China Accepted Article This article is protected by copyright.
    [Show full text]
  • Policy Disparities in Response to the First Wave of COVID-19 Between China and Germany Yuyao Zhang1, Leiyu Shi2, Haiqian Chen1, Xiaohan Wang1 and Gang Sun1,2*
    Zhang et al. International Journal for Equity in Health (2021) 20:86 https://doi.org/10.1186/s12939-021-01424-3 RESEARCH Open Access Policy disparities in response to the first wave of COVID-19 between China and Germany Yuyao Zhang1, Leiyu Shi2, Haiqian Chen1, Xiaohan Wang1 and Gang Sun1,2* Abstract Objective: Our research summarized policy disparities in response to the first wave of COVID-19 between China and Germany. We look forward to providing policy experience for other countries still in severe epidemics. Methods: We analyzed data provided by National Health Commission of the People’s Republic of China and Johns Hopkins University Coronavirus Resource Center for the period 10 January 2020 to 25 May 252,020. We used generalized linear model to evaluate the associations between the main control policies and the number of confirmed cases and the policy disparities in response to the first wave of COVID-19 between China and Germany. Results: The generalized linear models show that the following factors influence the cumulative number of confirmed cases in China: the Joint Prevention and Control Mechanism; locking down the worst-hit areas; the highest level response to public health emergencies; the expansion of medical insurance coverage to suspected patients; makeshift hospitals; residential closed management; counterpart assistance. The following factors influence the cumulative number of confirmed cases in Germany: the Novel Coronavirus Crisis Command; large gathering cancelled; real-time COVID-19 risk assessment; the medical emergency plan; schools closure; restrictions on the import of overseas epidemics; the no-contact protocol. Conclusions: There are two differences between China and Germany in non-pharmaceutical interventions: China adopted the blocking strategy, and Germany adopted the first mitigation and then blocking strategy; China’s goal is to eliminate the virus, and Germany’s goal is to protect high-risk groups to reduce losses.
    [Show full text]
  • Coinfection and Other Clinical Characteristics of COVID-19 In
    Coinfection and Other Clinical Characteristics of COVID-19 in Children Qin Wu, MD,a,p Yuhan Xing, MD,b,p Lei Shi, MB,a,p Wenjie Li, MS,a Yang Gao, MS,a Silin Pan, PhD, MD,a Ying Wang, MS,c Wendi Wang, MS,a Quansheng Xing, PhD, MDa BACKGROUND AND OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is abstract a newly identified pathogen that mainly spreads by droplets. Most published studies have been focused on adult patients with coronavirus disease 2019 (COVID-19), but data concerning pediatric patients are limited. In this study, we aimed to determine epidemiological characteristics and clinical features of pediatric patients with COVID-19. METHODS: We reviewed and analyzed data on pediatric patients with laboratory-confirmed COVID-19, including basic information, epidemiological history, clinical manifestations, laboratory and radiologic findings, treatment, outcome, and follow-up results. RESULTS: A total of 74 pediatric patients with COVID-19 were included in this study. Of the 68 case patients whose epidemiological data were complete, 65 (65 of 68; 95.59%) were household contacts of adults. Cough (32.43%) and fever (27.03%) were the predominant symptoms of 44 (59.46%) symptomatic patients at onset of the illness. Abnormalities in leukocyte count were found in 23 (31.08%) children, and 10 (13.51%) children presented with abnormal lymphocyte count. Of the 34 (45.95%) patients who had nucleic acid testing results for common respiratory pathogens, 19 (51.35%) showed coinfection with other pathogens other than SARS-CoV-2. Ten (13.51%) children had real-time reverse transcription polymerase chain reaction analysis for fecal specimens, and 8 of them showed prolonged existence of SARS-CoV-2 RNA.
    [Show full text]
  • CONNECTION the Official Newsletter of Zhejiang University Issue 16 Feb.2020
    CONNECTION The Official Newsletter of Zhejiang University Issue 16 Feb.2020 COVID-19 Special Issue Stand Strong Message from Editor-in-Chief CONNECTION Welcome to the special COVID-19 issue of Issue 16 CONNECTION, which highlights the efforts and contributions of ZJU community in face of the epidemic. As a group, they are heroes in harm's way, givers and doers who respond swiftly to the need of our city, our country and the world. When you read their stories, you'll recognize the strength and solidarity that define all ZJUers. ZJU community has demonstrated its courage and resilience in the battle against the novel coronavirus. At this time, let us all come together to protect ourselves and our loved ones, keep all those who are at the front lines in our prayers and pass on our gratitude to those who have joined and contributed to the fight against the virus. Together, we will weather this crisis. LI Min, Editor-in-Chief Director, Office of Global Engagement Editorial office : Global Communications Office of Global Engagement, Zhejiang University 866 Yuhangtang Road, Hangzhou, P.R. China 310058 Phone: +86 571 88981259 Fax: +86 571 87951315 Email: [email protected] Edited by : CHEN Weiying, AI Ni Designed by : HUANG Zhaoyi Material from Connection may be reproduced accompanied with appropriate acknowledgement. CONTENTS Faculty One of the heroes in harm’s way: LI Lanjuan 03 ZJU medics answered the call from Wuhan 04 Insights from ZJU experts 05 Alumni Fund for Prevention and Control of Viral Infectious Diseases set up 10 Alumni community mobilized in the battle against COVID-19 11 Education Classes start online during the epidemic 15 What ZJUers feel about online learning 15 Efforts to address concerns, avoid misinformation 17 International World standing with us 18 International students lending a hand against the epidemic 20 What our fans say 21 FacultyFaculty ZJU community has taken on the responsibility to join the concertedZJU community efforts has takenagainst on thethe responsibility spreadto join the of concerted the virus.
    [Show full text]
  • 1. Sars-Cov Nucleocapsid Protein Epitopes and Uses Thereof
    www.engineeringvillage.com Citation results: 500 Downloaded: 4/24/2020 1. SARS-COV NUCLEOCAPSID PROTEIN EPITOPES AND USES THEREOF KELVIN, David; PERSAD, Desmond; CAMERON, Cheryl; BRAY, Kurtis, R.; LOFARO, Lori, R.; JOHNSON, Camille; SEKALY, Rafick-Pierre; YOUNES, Souheil-Antoine; CHONG, Pele Assignee: UNIVERSITY HEALTH NETWORK; BECKMAN COULTER, INC.; UNIVERSITE DE MONTREAL; NATIONAL HEALTH RESEARCH INSTITUTES Publication Number: WO2005103259 Publication date: 11/03/2005 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 2. SARS-CoV-specific B-cell epitope and applications thereof Wu, Han-Chung; Liu, I-Ju; Chiu, Chien-Yu Assignee: National Taiwan University Publication Number: US20060062804 Publication date: 03/23/2006 Kind: Utility Patent Application Database: US Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 3. A RECOMBINANT SARS-COV VACCINE COMPRISING ATTENUATED VACCINIA VIRUS CARRIERS QIN, Chuan; WEI, Qiang; GAO, Hong; TU, Xinming; CHEN, Zhiwei; ZHANG, Linqi; HO, David, D. Assignee: INSTITUTE OF LABORATORY ANIMAL SCIENCE OF CHINESE ACADEMY OF MEDICAL SCIENCES; THE AARON DIAMOND AIDS RESEARCH CENTER; QIN, Chuan; WEI, Qiang; GAO, Hong; TU, Xinming; CHEN, Zhiwei; ZHANG, Linqi; HO, David, D. Publication Number: WO2006079290 Publication date: 08/03/2006 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data
    [Show full text]
  • Emergency Architecture. Modular Construction of Healthcare Facilities As a Response to Pandemic Outbreak
    E3S Web of Conferences 274, 01013 (2021) https://doi.org/10.1051/e3sconf/202127401013 STCCE – 2021 Emergency architecture. Modular construction of healthcare facilities as a response to pandemic outbreak Marina Smolova1, and Daria Smolova2[0000-0002-2297-0505] 1Kazan State University of Architecture and Engineering, 420043 Kazan, Russia 2NFOE Inc., QC H2Y 2W7 Montreal, Canada Abstract. Emerging infectious diseases originating from wildlife species continue to demolish humankind leaving an imprint on human history. December 2019 has marked the emergence of a novel coronavirus named SARS-CoV-2 (Covid-2019) originated in China in the city of Wuhan. Drastic emergence and spread of infectious disease have shown to appear in highly densified areas causing rapid spread of epidemic through population movement, transmission routes, major activity nodes, proximity, and connectivity of urban spaces. An extreme number of cases rising throughout the world caused space unavailability in healthcare facilities to serve patients infected with Covid-2019, therefore urging for innovative emergency management response from construction and architecture industry. Prefabricated modular construction has been widely utilized around the globe assembling rapid response facilities after catastrophic events such as tornadoes, hurricanes, and forest fires. An increasing number of Covid-2019 cases demanded effective and compressed implementation of medical centres to provide expeditious and secure healthcare. The paper examines the potential of standardization of modular construction of hospitals as a response to current and potential pandemic outbreaks. The research provides fundamental planning requirements of isolation units and their design flexibility as a key to rapid emergency solution. Keywords. Modular construction, prefabrication, prefabricated construction, emergency architecture, healthcare facilities, hospitals, prefabricated architecture, Covid-2019.
    [Show full text]
  • Lopinavir/Ritonavir for COVID-19: a Living Systematic Review Doi: 10.5867/Medwave.2020.06.7966
    Lopinavir/ritonavir for COVID-19: A living systematic review doi: 10.5867/medwave.2020.06.7966 Appendix 3: Included, excluded and ongoing studies - Lopinavir/ritonavir for COVID-19: A living systematic review Included randomised trials LOTUS China (1,2) Details or comments REFERENCES Publication thread for LOTUS China Epistemonikos Chen et al (1) Type: Journal article Epistemonikos | DOI ChiCTR2000029387 (2) Type:Trial registry (Chinese Clinical Trial Registry) Epistemonikos | DOI (not available) STUDY DESIGN QUOTE: ☑Randomised trial Single centre , open-label, individually randomized, controlled trial; ☐Comparative, non- randomised Eligible patients were randomly assigned in a 1:1 ratio; ☐Non-comparative study To balance the distribution of oxygen support between the two groups as an indicator of severity of respiratory failure, randomization was stratified on the basis of respiratory support methods at the time of enrollment: no oxygen support or oxygen support with nasal duct or mask, or high-flow oxygen, noninvasive ventilation, or invasive ventilation including ECMO. The permuted block (four patients per block) randomization sequence, including stratification, was prepared by a statistician not involved in the trial, using SAS software, version 9.4 (SAS Institute). POPULATION: INCLUSION QUOTE: CRITERIA Patients were assessed for eligibility on the basis of a positive reverse-transcriptase– ☐COVID-19 polymerase-chain-reaction (RT-PCR) assay) for SARS-CoV-2 in a respiratory tract ☑COVID-19 pneumonia sample Male and nonpregnant female patients 18 years of age or older were eligible if they had a diagnostic specimen that was positive on RT-PCR, had pneumonia ☐Severe COVID-19 pneumonia confirmed by chest imaging, had an oxygen saturation of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen to the fraction 1 / 27 Lopinavir/ritonavir for COVID-19: A living systematic review doi: 10.5867/medwave.2020.06.7966 of inspired oxygen at or below 300 mg Hg.
    [Show full text]
  • Clinical Course and Risk Factors for In-Hospital Death in Critical COVID-19 in Wuhan, China
    medRxiv preprint doi: https://doi.org/10.1101/2020.09.26.20189522; this version posted September 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Clinical Course And Risk Factors For In-hospital Death In Critical COVID-19 In Wuhan, China Fei Li, MD, PhD1,2#, Yue Cai, MD1,2#, Chao Gao, MD, PhD1#, Lei Zhou, MD, PhD2,3#, Renjuan Chen, MD, PhD1, Kan Zhang, MD1,2, Weiqin Li, MD2,4, Ruining Zhang, MD1, Xijing Zhang, MD, PhD2,5, Duolao Wang, PhD 6*, Yi Liu, MD, PhD1*, Ling Tao, MD, PhD1* 1. Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an, China 2. Huoshenshan Hospital, Wuhan, China 3. Clinical Laboratory, Xijing Hospital, Fourth Military Medical University, Xi’an, China 4. Department of Critical Care Medicine, Jinling Hospital, Nanjing, China 5. Surgical ICU, Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi’an, China 6. Department of Clinical Sciences Liverpool School of Tropical Medicine Pembroke, Liverpool, United Kingdom Address for correspondence: Professor Ling Tao, MD, PhD. Professor of Cardiology – Xijing hospital, Xi’an, China 127 Changle west road, Xi’an, 710032, China Email: [email protected] Professor Yi Liu, MD, PhD. Professor of Cardiology – Xijing hospital, Xi’an, China 127 Changle west road, Xi’an, 710032, China Email: liuyimeishan@hotmail,.com 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
    [Show full text]
  • A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, Phd; Karen A
    BRIEF REPORT Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January–February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, PhD; Karen A. Grépin, PhD; Hai Liang, PhD; Isaac Chun-Hai Fung, PhD ABSTRACT Objective: Awareness and attentiveness have implications for the acceptance and adoption of disease prevention and control measures. Social media posts provide a record of the public’s attention to an outbreak. To measure the attention of Chinese netizens to coronavirus disease 2019 (COVID-19), a pre-established nationally representative cohort of Weibo users was searched for COVID-19-related key words in their posts. Methods: COVID-19-related posts (N = 1101) were retrieved from a longitudinal cohort of 52 268 randomly sampled Weibo accounts (December 31, 2019–February 12, 2020). Results: Attention to COVID-19 was limited prior to China openly acknowledging human-to-human transmis- sion on January 20. Following this date, attention quickly increased and has remained high over time. Particularly high levels of social media traffic appeared around when Wuhan was first placed in quarantine (January 23–24, 8–9% of the overall posts), when a scandal associated with the Red Cross Society of China occurred (February 1, 8%), and, following the death of Dr Li Wenliang (February 6–7, 11%), one of the whis- tleblowers who was reprimanded by the Chinese police in early January for discussing this outbreak online. Conclusion: Limited early warnings represent missed opportunities to engage citizens earlier in the out- break. Governments should more proactively communicate early warnings to the public in a transparent manner.
    [Show full text]
  • The Wuhan Coronavirus and Its Impact on China's Foreign Relations
    12 2 April 2020 The Wuhan Coronavirus and Its Impact on China’s Foreign Relations – Part One Lindsay Hughes Senior Research Analyst Indo-Pacific Research Programme Key Points China has semi-officially denied that the coronavirus that is currently sweeping across the world originated there. Beijing has also claimed that it is a role model in its handling of the pandemic. Those claims are vigorously disputed by Western countries. The West is also becoming increasingly exasperated with China’s lies, double standards and apparent willingness to steal, blackmail and coerce. The West is now re-evaluating its individual and collective relationships with China. Summary The Covid-19 pandemic, which has swept through many parts of the world, had infected over 330,000 people globally at the time of writing and caused around 15,000 deaths by 23 March. In Australia, the number of confirmed cases has moved past 1,700, with 37 per cent of those being reported between 21 March and 23 March. This graph below shows the infection rate in Australia. In the US, the number of confirmed Covid-19 cases had surpassed 32,000 by 23 March, having grown ten-fold from a week earlier. New Zealand moved to the highest state of alert and closed its schools on 25 March, while India declared a “people’s curfew” on 22 March, leading to virtually empty streets in the capital, New Delhi, and in its financial capital, Mumbai. While most Indians complied with the curfew, many did not, leading the government there to declare that those who violated the curfew would face up to six months imprisonment.
    [Show full text]
  • A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, Phd; Karen A
    BRIEF REPORT Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January–February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, PhD; Karen A. Grépin, PhD; Hai Liang, PhD; Isaac Chun-Hai Fung, PhD ABSTRACT Objective: Awareness and attentiveness have implications for the acceptance and adoption of disease prevention and control measures. Social media posts provide a record of the public’s attention to an outbreak. To measure the attention of Chinese netizens to coronavirus disease 2019 (COVID-19), a pre-established nationally representative cohort of Weibo users was searched for COVID-19-related key words in their posts. Methods: COVID-19-related posts (N = 1101) were retrieved from a longitudinal cohort of 52 268 randomly sampled Weibo accounts (December 31, 2019–February 12, 2020). Results: Attention to COVID-19 was limited prior to China openly acknowledging human-to-human transmis- sion on January 20. Following this date, attention quickly increased and has remained high over time. Particularly high levels of social media traffic appeared around when Wuhan was first placed in quarantine (January 23–24, 8–9% of the overall posts), when a scandal associated with the Red Cross Society of China occurred (February 1, 8%), and, following the death of Dr Li Wenliang (February 6–7, 11%), one of the whis- tleblowers who was reprimanded by the Chinese police in early January for discussing this outbreak online. Conclusion: Limited early warnings represent missed opportunities to engage citizens earlier in the out- break. Governments should more proactively communicate early warnings to the public in a transparent manner.
    [Show full text]
  • An Exploratory Randomized, Controlled Study on the Efficacy and Safety Of
    medRxiv preprint doi: https://doi.org/10.1101/2020.03.19.20038984; this version posted March 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. 1 An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI) Yueping Li1,*, Zhiwei Xie1,*, Weiyin Lin1,*, Weiping Cai1,*, Chunyan Wen1, Yujuan Guan1, Xiaoneng Mo3, Jian Wang1, Yaping Wang1, Ping Peng3, Xudan Chen1, Wenxin Hong1, Guangming Xiao1, Jinxin Liu5, Lieguang Zhang5, Fengyu Hu4, Feng Li4, Fuchun Zhang1,#, Xilong Deng2,#, Linghua Li1,#. 1 Infectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510060, China 2Intensive Care Unit, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510440, China 3 Department of Respiration, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510440, China 4Institute of Infectious Diseases, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510060, China 5Department of Radiology, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510440, China * Yueping Li, Zhiwei Xie, Weiyin Lin and Weiping Cai contributed equally. NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1 medRxiv preprint doi: https://doi.org/10.1101/2020.03.19.20038984; this version posted March 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
    [Show full text]